[
    [
        {
            "time": "",
            "original_text": "巨 · 研究 | 医药外包四大赛道增长明确 大分子生产研发外包服务确定性最高",
            "features": {
                "keywords": [
                    "医药外包",
                    "大分子",
                    "生产研发",
                    "外包服务",
                    "确定性"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "巨 · 研究 | 医药外包四大赛道增长明确 大分子生产研发外包服务确定性最高",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "【民生医药|周报】3/15：大盘出现调整，全球产业链定价能力强和内需驱动的医药细分龙头投资性价比凸显",
            "features": {
                "keywords": [
                    "大盘调整",
                    "全球产业链",
                    "定价能力",
                    "内需驱动",
                    "医药细分龙头",
                    "投资性价比"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【民生医药|周报】3/15：大盘出现调整，全球产业链定价能力强和内需驱动的医药细分龙头投资性价比凸显",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]